Nose Deformity Clinical Trial
Official title:
Mindfulness Meditation to Improve Patient Satisfaction and Post-operative Outcomes in Rhinoplasty Patients: A Randomized Controlled Trial
Verified date | March 2021 |
Source | Johns Hopkins University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
A key factor in determining success of facial plastic plastic surgery is overall patient satisfaction. While a number of patient-reported outcomes tools has been developed, there is still limited research in how physicians can improve patient satisfaction and post-operative outcomes. The goal of this study is to investigate the effect of a mindfulness meditation phone application on rhinoplasty outcomes. This study will also explore whether mindfulness meditation is a feasible adjunct to current pharmacological modalities of postoperative pain control as well as its potential impact on patient satisfaction. These questions will be answered using a randomized controlled trial.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | December 31, 2022 |
Est. primary completion date | December 31, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients 18 years of age or older - Patients who will undergo rhinoplasty - Patients with access to a smart-phone Exclusion Criteria: - Patients younger than 18 years of age - Non-English speakers - Patients without smart-phone access |
Country | Name | City | State |
---|---|---|---|
United States | Johns Hopkins Hospital | Baltimore | Maryland |
United States | Johns Hopkins - Green Spring Station | Lutherville-Timonium | Maryland |
Lead Sponsor | Collaborator |
---|---|
Johns Hopkins University |
United States,
Cosmetic Surgery National Data Bank Statistics. Aesthet Surg J. 2016 Apr;36 Suppl 1:1-29. doi: 10.1093/asj/36.Supplement_1.1. — View Citation
Guendelman S, Medeiros S, Rampes H. Mindfulness and Emotion Regulation: Insights from Neurobiological, Psychological, and Clinical Studies. Front Psychol. 2017 Mar 6;8:220. doi: 10.3389/fpsyg.2017.00220. eCollection 2017. Review. — View Citation
Klassen AF, Cano SJ, Scott A, Snell L, Pusic AL. Measuring patient-reported outcomes in facial aesthetic patients: development of the FACE-Q. Facial Plast Surg. 2010 Aug;26(4):303-9. doi: 10.1055/s-0030-1262313. Epub 2010 Jul 27. — View Citation
Perry F, Parker RK, White PF, Clifford PA. Role of psychological factors in postoperative pain control and recovery with patient-controlled analgesia. Clin J Pain. 1994 Mar;10(1):57-63; discussion 82-5. — View Citation
Vaughn F, Wichowski H, Bosworth G. Does preoperative anxiety level predict postoperative pain? AORN J. 2007 Mar;85(3):589-604. Review. — View Citation
Zeidan F, Vago DR. Mindfulness meditation-based pain relief: a mechanistic account. Ann N Y Acad Sci. 2016 Jun;1373(1):114-27. doi: 10.1111/nyas.13153. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Patient Satisfaction with patient's Nose as measured by the FACE-Q Satisfaction with Nose Scale | FACE-Q Satisfaction with Nose scale is a 10-item questionnaire with minimum score 10, maximum score 40 assessing patient satisfaction with patient's nose; each item on the questionnaire can be answered between a range of 1 (very dissatisfied) to 4 (very satisfied) with higher scores indicating greater satisfaction with patient's nose | Baseline (prior to intervention), postoperatively at 2 weeks and 4 weeks | |
Primary | Change in Patient Satisfaction with patient's Nose as measured by the Rhinoplasty Outcome Evaluation scale | Rhinoplasty Outcome Evaluation scale is a 6-item questionnaire with minimum score of 0 and maximum score of 24 assessing patient satisfaction with patient's nose; each item on the questionnaire can be answered between a range of 0 to 4 regarding statements related to patient's nose with higher scores indicating greater satisfaction with patient's nose | Baseline (prior to intervention), postoperatively at 2 weeks and 4 weeks | |
Secondary | Pain as measured by Visual Analog Scale | Pain Visual Analog Scale - single-item question ranging from 0 to 100 with greater numbers indicating more pain experienced after surgery | Postoperatively at day 2, 2 weeks and 4 weeks | |
Secondary | Pain Control as measured by Prescription Analgesic Use | Pain control as measured by prescription analgesic use will be confirmed at the routine postoperative follow-up appointment by prescription pain medication pill-counting to ascertain analgesic usage over the recovery period | Single measure postoperatively at routine follow-up appointment up to 1 month post procedure | |
Secondary | Screen for Body Dysmorphic Disorder as measured by the Body Dysmorphic Disorder Questionnaire | Body Dysmorphic Disorder Questionnaire (BDDQ) - 4-item questionnaire with yes/no responses related to concerns about physical appearance; a "positive" screen per the BDDQ instruction manual suggests the possibility of body dysmorphic disorder but is not diagnostic | Baseline (prior to intervention) | |
Secondary | Change in Anxiety as measured by the State-Trait Anxiety Inventory | State-Trait Anxiety Inventory - 20-item questionnaire with minimum score of 20 and maximum score of 80 (with higher scores meaning more anxiety) intended to measure state anxiety with categorical responses ranging from "never" to "very much so" (4-point Likert scale) in regards to statements about how one feels at the current moment (state) and more generally (trait) | Baseline (prior to intervention), 2 weeks, 4 weeks | |
Secondary | Change in Mindfulness as measured by the Cognitive and Affective Mindfulness Scale-Revised | Cognitive and Affective Mindfulness Scale-Revised - 12-item questionnaire with a minimum score of 12 points and a maximum score of 48 tallied by categorical responses ranging from "rarely/not at all" (1) to "almost always" (4) per item regarding statements about one's experience of mindfulness where higher scores indicate greater mindful qualities | Baseline (prior to intervention), 2 weeks, 4 weeks | |
Secondary | Early Postoperative Symptoms as measured by FACE-Q Recovery Early Symptoms Scale | FACE-Q Recovery Early Symptoms scale - 17-item questionnaire with minimum score 17 and maximum score 68 assessing early symptoms after surgery; each item on the questionnaire can be answered between a range of 1 (not at all) to 4 (extremely) regarding specific symptoms participants may or may not be experiencing after surgery with higher scores indicating greater discomfort, more symptoms, or both | Postoperatively at day 2 | |
Secondary | Patient Satisfaction with Doctor as measured by FACE-Q Satisfaction with Doctor Scale | FACE-Q Satisfaction with Doctor scale - 10-item questionnaire with minimum score 10 and maximum score 40 assessing patient satisfaction with patient's doctor; each item on the questionnaire can be answered between a range of 1 (definitely disagree) to 4 (definitely agree) with higher scores indicating greater satisfaction with patient's doctor | Postoperatively at 4 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Suspended |
NCT03624608 -
Evaluation of the Auryzon Devices in the Optimization of Ear and Nose Reconstruction Procedures
|
N/A | |
Completed |
NCT03748459 -
Rhinoplasty Scar Comparison
|
||
Recruiting |
NCT02348931 -
Clinical Effect of a Nasal Former in Nasal Deformities
|
Phase 3 |